• Go to navigation
  • Go to content
Anaesthesia-az.com

Astrazeneca Worldwide

  • AstraZeneca Websites
az.com

Main navigation

  • Home
  • Knowlege Bank
  • Atlas of Anaesthesia
  • Diprivan
    • About Diprivan
      • Technical Monograph
      • Global Prescribing Information
      • Target Controlled Infusion
      • Dosage
      • Indications
    • General Anaesthesia
    • Diprifusor
    • Interactive Tutorial
    • Questions & Answers
  • Naropin
  • EMLA

You are here

  • Home
  • Diprivan
  • About Diprivan
  • 'Global Leaders in Anaesthesia'

This section describes the licensed indications of Diprivan (propofol)

Diprivan (propofol) is indicated for:

Induction and maintenance of general anaesthesia

Sedation of ventilated adult patients receiving intensive care

Conscious sedation for surgical and diagnostic procedures

Diprivan (propofol) is indicated for use in the elderly and for children over 1 month old.

Note:
Administration of Diprivan (propofol) by a Diprifusor TCI system is restricted to induction and maintenance of general anaesthesia in adults. It is not recommended for use in ICU sedation or conscious sedation or in children.

Page tools

  • Print
  • Bookmark this page

Contact

Contact us

Information for

This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below:

  • US Citizens
  • UK Citizens
  • Patients (non US & UK)
  • Journalists
AstraZeneca

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2008